Adaptive two-stage designs in phase II clinical trials
- 14 February 2006
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 25 (19) , 3382-3395
Abstract
Two-stage designs have been widely used in phase II clinical trials. Such designs are desirable because they allow a decision to be made on whether a treatment is effective or not after the accumulation of the data at the end of each stage. Optimal fixed two-stage designs, where the sample size at each stage is fixed in advance, were proposed by Simon when the primary outcome is a binary response. This paper proposes an adaptive two-stage design which allows the sample size at the second stage to depend on the results at the first stage. Using a Bayesian decision-theoretic construct, we derive optimal adaptive two-stage designs; the optimality criterion being minimum expected sample size under the null hypothesis. Comparisons are made between Simon's two-stage fixed design and the new design with respect to this optimality criterion. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 6 references indexed in Scilit:
- Optimal asymmetric one-sided group sequential testsBiometrika, 2002
- R: A Language for Data Analysis and GraphicsJournal of Computational and Graphical Statistics, 1996
- Computational Methods for Semiparametric Linear Regression with Censored DataJournal of Computational and Graphical Statistics, 1992
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Efficient group sequential tests with unpredictable group sizesBiometrika, 1987
- Optimal Stopping and Sequential Tests which Minimize the Maximum Expected Sample SizeThe Annals of Statistics, 1973